Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

DNA-Inspired Multi-Functional Double-Cross-Linking Self-Healing Hydrogel Promotes the Healing of Diabetic Wounds

Yang P., Hu Y., Ju Y., Hsiung N., Ye J., Jian A.

Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Adv Sci (Weinh) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Sci (Weinh) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41309520
PMCID
PMC12884814
DOI
10.1002/advs.202513784
Citations
1

Abstract (original English)

The impaired healing of diabetic wounds caused by microenvironmental imbalances presents a significant clinical challenge. In this study, a deoxyribonucleic acid (DNA)-inspired, self-healing hydrogel-based delivery system-ATG@Exo Cur -is developed that synergistically promotes diabetic wound healing by modulating multiple pathological processes. This system features a double-crosslinked, self-healing hydrogel derived from natural polysaccharides, which leverages the principle of DNA base-pairing to achieve controlled drug release and mechanical adaptability. Additionally, incorporating exosome-loaded curcumin enhances its physicochemical stability and improves the targeted delivery efficiency. This study demonstrates that ATG@Exo Cur effectively scavenges reactive oxygen species, suppresses chronic inflammation, promotes angiogenesis, and modulates the immune microenvironment by inducing macrophage polarization toward a pro-repair phenotype. By integrating biomaterial engineering with biological activity, this system overcomes the limitations of monotherapies and offers a novel, highly efficient, and safe approach for treating chronic diabetic wounds.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansMiceDiabetes Mellitus, ExperimentalCurcuminDNAHydrogelsCross-Linking ReagentsDrug Delivery SystemsWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research